Lorediplon (Ferrer)

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLorediplon (Ferrer)
Drug Alias NameLorediplonum洛瑞普隆罗利普隆GF-015535-00
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor modulators
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsSleep Initiation and Maintenance Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesFerrer
China Registration ClassN/A

Develop Information

Active CompaniesFerrer
Inactive CompaniesN/A
Active IndicationsSleep Initiation and Maintenance Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipedia